LP429469-2
Brexpiprazole
Active
Description
Brexpiprazole is known as 'atypical' antipsychotic drug approved by the FDA in July 2015 for treatment of schizophrenia and adjunctive therapy for major depressive disorder. [PMID: PMC6007711] Source: Regenstrief LOINC
Basic Part Properties
- Name
- Brexpiprazole
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2021-09-03
- Construct for LOINC Short Name
- Brexpiprazole
LOINC Terminology Service (API) using HL7® FHIR®
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP429469-2 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP429469-2
Language Variants
| Tag | Language | Translation |
|---|---|---|
| it-IT | Italian (Italy) | Brexpiprazolo |
| nl-NL | Dutch (Netherlands) | brexpiprazol |
| es-ES | Spanish (Spain) | Brexpiprazol |
| zh-CN | Chinese (China) | 依匹哌唑 Synonyms: |
LOINC Copyright
Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright